Members of the Brigham Health executive leadership team welcome representatives from Boao Evergrande International Hospital in affiliation with Brigham and Women’s Hospital.

Physicians from a new hospital opening in China spent a week at BWH and Dana-Farber Cancer Institute (DFCI) last month to observe both institutions’ approach to providing high-quality care.

For the last two years, Brigham Health has provided strategic guidance as Evergrande Health develops a nationwide health care system in China. Evergrande’s first hospital, Boao Evergrande International Hospital in affiliation with Brigham and Women’s Hospital, is scheduled to open in 2018. The new hospital, located in China’s Hainan province, will specialize in oncology, initially focusing on breast cancer. BWH and DFCI are working in collaboration to advise Evergrande on both clinical and operational aspects of providing care.

Led by the Brigham Health Business Development and Strategic Initiatives (BDSI) group, more than 50 experts in clinical specialties and hospital functions from the Brigham have been part of the Evergrande Health collaboration since 2015.

Most recently, the visiting physicians sought to learn how BWH approaches all facets of hospital operations, including environmental services, quality and safety, pharmacy, nursing and more. They received tours of the Emergency Department, Medical Intensive Care Unit and Advanced Multimodality Image Guided Operating (AMIGO) suite. The visitors also met with clinical leaders at DFCI, an essential partner in developing a multidisciplinary model of cancer care at the hospital in Boao.

“Improving and expanding health care locally and internationally is integral to our mission and supports our financial health, and this collaboration with our expert BWH and DFCI colleagues is a great example of what’s possible,” said Mark Davis, MD, MS, BDSI executive director.